Skip to main content

Table 1 HHV-6 DNA prevalence along the five scheduled visits

From: MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up

 

VB

6M

12M

18M

24M

HHV-6 DNA prevalence in serum

28 / 154

22 / 154

19 / 154

18 / 154

16 / 154

 

18.2%

14.3%

12.3%

11.7%

10.4%

p (between the basal visit and the 24-month visit)

0.050

OR (between the basal visit and the 24-month visit)

1.92 (0.95-3.91)